CME Corp. CEO KC Meleski named HIDA board chair

By AI, Created 2:36 PM UTC, June 03, 2026, /AGP/ – KC Meleski, president and CEO of CME Corp., has taken over as chair of the HIDA Board of Directors, a move that strengthens CME’s profile in healthcare distribution and industry advocacy. Meleski brings prior HIDA board experience and says he wants to help expand value for members and the providers they serve.

Why it matters: - KC Meleski now leads the Health Industry Distributors Association board at a time when healthcare distributors are focused on supply chain resilience and provider access to equipment. - The role gives CME Corp. a higher-profile voice in industry advocacy and policy discussions.

What happened: - CME Corp. announced that KC Meleski has assumed the role of chair of the HIDA Board of Directors. - Meleski previously served as HIDA’s chairman-elect. - Meleski succeeds Kelley Moffett. - HIDA President and CEO Matthew J. Rowan said Meleski is well positioned to advance the board’s work.

The details: - Meleski has been a HIDA member since 2018. - His HIDA service includes the Acute Care Advisory Council and the HIDA Board of Directors. - Meleski previously served as HIDA treasurer. - Meleski joined CME in 2001 as an account manager for the Greater Boston area. - He became president of CME Corp. in 2024. - He added the CEO title in April 2026. - CME says its national footprint and reputation with healthcare providers have continued to grow under Meleski’s leadership. - CME Corp. describes itself as a specialty distributor of healthcare, laboratory and imaging equipment. - CME says its service model includes equipment acquisition, CAD-based layout and design, 3D modeling, warehousing, staging, assembly, just-in-time direct-to-site delivery, installation, and biomedical and technical services. - CME says all of those services are staffed by CME employees. - CME says it offers more than 2 million products sourced from more than 2,000 vendors. - CME says it has 25 locations across the country and is expanding.

Between the lines: - Meleski’s appointment suggests CME wants to pair company growth with broader industry influence. - HIDA’s leadership change also highlights the importance of distributors in helping healthcare systems acquire equipment efficiently.

What’s next: - Meleski is expected to help guide HIDA’s board agenda and member value strategy. - CME Corp. is likely to keep emphasizing national expansion and its end-to-end equipment acquisition model.

The bottom line: - Meleski’s rise to HIDA board chair strengthens both CME Corp.’s industry standing and its role in healthcare distribution leadership.